Skip to content

ZNDVPHQTJJACFM-UHFFFAOYSA-N

C35H43ClF3N5O7S — CID 139389159

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 5-[3-[3-[[2-chloro-6-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]phenoxy]propyl]-2,2-dimethylpyrrolidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1C(CCCOc2cccc(S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCCC5(C(F)(F)F)CC5)n4)nc3Cl)c2)CCC1(C)C
InChIInChI=1S/C35H43ClF3N5O7S/c1-32(2,3)51-31(46)44-23(13-15-33(44,4)5)8-7-20-49-24-9-6-10-25(22-24)52(47,48)42-30(45)26-11-12-27(40-29(26)36)43-19-14-28(41-43)50-21-18-34(16-17-34)35(37,38)39/h6,9-12,14,19,22-23H,7-8,13,15-18,20-21H2,1-5H3,(H,42,45)
InChIKeyZNDVPHQTJJACFM-UHFFFAOYSA-N
MW770.27 g/mol
LogP7.49
Rot. Bonds13

About ZNDVPHQTJJACFM-UHFFFAOYSA-N

ZNDVPHQTJJACFM-UHFFFAOYSA-N (PubChem CID 139389159) has the molecular formula C35H43ClF3N5O7S and a molecular weight of 770.27 g/mol. Its IUPAC name is tert-butyl 5-[3-[3-[[2-chloro-6-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]phenoxy]propyl]-2,2-dimethylpyrrolidine-1-carboxylate.

Molecular Properties

Compound NameZNDVPHQTJJACFM-UHFFFAOYSA-N
PubChem CID139389159
Molecular FormulaC35H43ClF3N5O7S
Molecular Weight770.27 g/mol
Exact Mass769.25
IUPAC Nametert-butyl 5-[3-[3-[[2-chloro-6-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]phenoxy]propyl]-2,2-dimethylpyrrolidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1C(CCCOc2cccc(S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCCC5(C(F)(F)F)CC5)n4)nc3Cl)c2)CCC1(C)C
InChIInChI=1S/C35H43ClF3N5O7S/c1-32(2,3)51-31(46)44-23(13-15-33(44,4)5)8-7-20-49-24-9-6-10-25(22-24)52(47,48)42-30(45)26-11-12-27(40-29(26)36)43-19-14-28(41-43)50-21-18-34(16-17-34)35(37,38)39/h6,9-12,14,19,22-23H,7-8,13,15-18,20-21H2,1-5H3,(H,42,45)
InChIKeyZNDVPHQTJJACFM-UHFFFAOYSA-N
XLogP7.49
TPSA141.95 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms52
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500770.27
LogP ≤ 57.49
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze ZNDVPHQTJJACFM-UHFFFAOYSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ZNDVPHQTJJACFM-UHFFFAOYSA-N?
The IUPAC name of ZNDVPHQTJJACFM-UHFFFAOYSA-N (CID 139389159) is tert-butyl 5-[3-[3-[[2-chloro-6-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]phenoxy]propyl]-2,2-dimethylpyrrolidine-1-carboxylate.
What is the SMILES notation for ZNDVPHQTJJACFM-UHFFFAOYSA-N?
The canonical SMILES for ZNDVPHQTJJACFM-UHFFFAOYSA-N is CC(C)(C)OC(=O)N1C(CCCOc2cccc(S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCCC5(C(F)(F)F)CC5)n4)nc3Cl)c2)CCC1(C)C.
What is the InChIKey of ZNDVPHQTJJACFM-UHFFFAOYSA-N?
The InChIKey is ZNDVPHQTJJACFM-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H43ClF3N5O7S/c1-32(2,3)51-31(46)44-23(13-15-33(44,4)5)8-7-20-49-24-9-6-10-25(22-24)52(47,48)42-30(45)26-11-12-27(40-29(26)36)43-19-14-28(41-43)50-21-18-34(16-17-34)35(37,38)39/h6,9-12,14,19,22-23H,7-8,13,15-18,20-21H2,1-5H3,(H,42,45).
What are the key properties of ZNDVPHQTJJACFM-UHFFFAOYSA-N?
ZNDVPHQTJJACFM-UHFFFAOYSA-N has a molecular weight of 770.27 g/mol, XLogP of 7.49, 13 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for ZNDVPHQTJJACFM-UHFFFAOYSA-N is sourced from PubChem (CID 139389159), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.